Healthcare Triangle Faces Nasdaq Delisting Amid Revenue Drop
By ATTN Desk · Editorial oversight: Sean Han
Healthcare Triangle Inc. (HCTI)
Introduction
Healthcare Triangle Inc. (NASDAQ: HCTI) is a Pleasanton, California–based provider of technology solutions and consulting services for healthcare and life-sciences organizations. Founded in 2020, the company supports providers, payors, hospitals, and pharmaceutical and life-sciences firms in areas such as cloud transformation, data management, interoperability, and clinical automation.
Corporate Structure
- Ticker: HCTI (NASDAQ)
- Headquarters: Pleasanton, California
- Founded: 2020
- Employees: 201–500 (LinkedIn)
- Board Composition: Majority independent directors with audit, compensation, and governance committees (2024 10-K)
- Subsidiaries and Acquisitions:
- QuantumNexis, an AI-powered subsidiary launched via the acquisitions of Niyama Digital Healthcare (mental wellness) and Ezovion (smart hospital platform)
- Asset purchase from SecureKloud Technologies Inc. valued at $7.44 million, paid in Series B Convertible Preferred Stock (2024 10-K)
Developments and News
- March 31, 2025 (10-K Filing):
- Revenue declined 65% to $11.7 million (2024 vs. 2023: $33.2 million)
- Net loss narrowed to $5.97 million (2024 vs. 2023: $8.69 million)
- Cost of revenue decreased 67% to $8.81 million; operating expenses were $7.64 million (2023: $14.47 million)
- Accounts receivable reduced from $3.6 million to $1.1 million
- Year-end cash and equivalents: $20,000 (vs. $1.23 million at December 31, 2023)
- Material weakness in internal controls over financial reporting identified
- March 3–6, 2025: Presentation at HIMSS 2025 in Las Vegas, NV, showcasing AI-driven documentation (Readabl.ai) and Epic Gold Star consulting
- May 20, 2025: Received a Nasdaq notice of potential delisting due to dilution from the private placement of Series A and B warrants; the deadline to submit a compliance plan is May 30, 2025
- May 20, 2025 (10-Q Filing): Quarterly report filed (Section 13/15(d)); details on Q1 2025 financials and operational updates available in the full document
- May 23 & May 30, 2025 (8-K Filings): Item 3.01 reports regarding Nasdaq compliance matters and related corporate actions
Financial and Strategic Analysis
| Metric | Value | Period / Source |
|---|---|---|
| Stock price (close) | $0.0280 (+204.35%) | June 11, 2025 |
| Trading volume | 289,695,417 shares | June 11, 2025 |
| Market capitalization | $3.76 million | Intraday (Yahoo Finance) |
| Revenue (TTM) | $11.29 million | Trailing 12 months to Mar 31, 2025 |
| Net income (TTM) | -$5.81 million | Trailing 12 months to Mar 31, 2025 |
| Profit margin | -51.43% | TTM |
| Total cash | $6.83 million | Most recent quarter |
| Total debt / equity | 9.04% | MRQ |
| Price/Sales | 0.01 | TTM |
| Price/Book | 3.29 | MRQ |
- Profitability and Cash Flow: Negative margins and net losses have persisted; levered free cash flow is -$3.87 million (TTM).
- Liquidity: Cash on hand increased to $6.83 million as of the most recent quarter, following a year-end balance of $20,000 on December 31, 2024.
- Capital Structure: Low debt relative to equity (9.04%); recent fundraising via private placements has led to potential dilution concerns.
- Strategy: Focus on AI-driven platforms (QuantumNexis), mergers and acquisitions (M&A) to expand service offerings, and participation in industry events. Identified internal control weaknesses may prompt enhancements to governance and reporting processes.
Market Position and Industry Context
Healthcare Triangle operates in the healthcare IT services and consulting sector, where companies compete on technology depth, regulatory compliance expertise, and domain knowledge. Key dynamics include:
- Regulatory Environment: HIPAA and HITECH compliance, data security standards (HITRUST certification)
- Technology Trends: AI-driven clinical documentation, cloud migration, interoperability (FHIR/EHR integration)
- Competitive Landscape: Global systems integrators, specialized health-tech firms, and emerging digital-health startups
- Trading Considerations: Potential move to the OTCQB market if Nasdaq delisting is not avoided; volatility reflected in a 204% share-price increase on June 11, 2025
TL;DR
- On May 20, 2025, Nasdaq notified Healthcare Triangle of potential delisting over warrant-related dilution; a compliance plan was due by May 30, 2025.
- FY 2024 revenue fell 65% to $11.7 million; net loss narrowed to $5.97 million. Year-end cash was $20,000.
- As of June 11, 2025, shares closed at $0.0280, up 204.35%, on high trading volume.
- The company is expanding its AI-focused portfolio through QuantumNexis and asset acquisitions while addressing internal controls and exploring alternative trading venues.